Cannot redeclare control with same name "grid_4_qv_cta_shadow_hover_box_shadow_position"
(NYSE: PFE) today announced the decision to discontinue development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, which was being investigated for chronic weight management
July 18, 2025: Chinese Obesity Drug Outperforms Zepbound in Helping Patients Lose Weight, Trials Show A new obesity drug, HRS9531, made by the Chinese company Hengrui Pharma may help patients lose more weight than when on Zepbound
These GLP-1RAs include once-weekly dulaglutide, exenatide and semaglutide (yet to be approved in Australia) and once-daily liraglutide (Table 2)
JAMA Internal Medicine (2016): In over 1.5 million patients, incretin-based drugs, including GLP-1s, had an adjusted hazard ratio of 1.04 (95% CI, 0.811.35) for acute pancreatitis
If anything looks wrong - if the cold packs are fully thawed and warm, if the medication is cloudy or discolored, or if the packaging is damaged - contact the pharmacy before using the medication
